Psoriasis patient source of business for major IL-23 agents
CRA analytics insight A higher proportion of Tremfya patients, versus Skyrizi patients, were previously treated with an IL-17 agent (i.e., Cosentyx or Taltz)...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Eddie Li is vice president and Head of the Analytics Center of Excellence in the Life Sciences Practice at CRA.
Mr. Li has more than 10 years of analytical consulting experience helping pharmaceutical clients across broad therapeutic areas. Mr. Li regularly leverages various data sources including pharmacy and medical claims, affiliations, prescriptions and marketing data to inform commercial strategy. He leads projects specializing in patient journey, patient finding, HEOR study, opportunity assessment, customer segmentation, and physician network analysis. As Head of the Analytics Center of Excellence, he provides guidance and oversight for internal R&D concerning machine-learning, cloud-based data platforms and interactive data visualization.